Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), has released a Request for Information (RFI) regarding a new initiative to lower prescription drug costs for Medicare recipients.
美国卫生与公共服务部（HHS），通过美国医疗保险和医疗补助服务（康哲药业），发布了有关降低药费的新倡议的信息请求（RFI），以造福于医保参与者。
The Medicare $2 Drug List Model, developed under President Biden's Executive Order 14087, seeks to offer certain generic drugs for a fixed copayment of no more than $2 per month.
医疗保险2美元药品清单模型，是在拜登总统的行政令14087号下制定的，旨在为某些通用药品提供每月不超过2美元的固定自付款。
This initiative targets commonly prescribed drugs for conditions like high cholesterol and high blood pressure.
此倡议旨在针对常见的高胆固醇和高血压等病症常开的处方药。
Also Read: Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets.
另请阅读：诺和诺德的奥泽匹克可能成为2027年医保议价目标之一。
The Center for Medicare and Medicaid Innovation (Innovation Center) has designed the Medicare $2 Drug List Model to test whether simplifying access to affordable, clinically important generics will improve health outcomes, improve medication adherence, and boost overall satisfaction with the Medicare Part D program.
医疗保险和医疗补助创新中心（创新中心）设计了医疗保险2美元药品清单模型，以测试简化获取价格实惠、临床重要的通用药品是否会提高健康结果，增进药物依从性，并提升对医保第D计划的整体满意度。
These drugs, which would not be subject to typical utilization management requirements, could be available at all participating pharmacies as early as January 2027.
这些药物不需要遵守传统的使用管理要求，最早可以在所有参与药房提供，且提供时间将是在2027年1月。
The initial list of drugs for the $2 Drug List Model has been carefully developed through a rigorous process. It incorporates input from physicians, pharmacists, and health policy experts to ensure that the selected medications address common conditions for Medicare recipients.
医疗保险2美元药品清单模型的初始药品清单经过严格的过程精心制定。它采纳了医生、药剂师和卫生政策专家的意见，以确保选定的药物能够解决医保参与者的常见病症。
The concept of a fixed-cost drug list is not new, with many retail pharmacies already offering generic medications at low, standardized prices.
固定成本药品清单的概念并不新鲜，许多零售药店已经以低价标准化的价格提供通用药品。
However, the Medicare $2 Drug List Model will be tailored specifically to Medicare recipients.
然而，康哲药业2美元药品目录模式将专门针对医疗保险受益人定制。
Last week, the HHS released final guidance for the second Medicare Drug Price Negotiation Program cycle.
上周，卫生与公共服务部发布了第二轮医疗保险药品价格谈判计划的最终指导方针。
This initiative aims to provide lower drug prices starting in 2026 and 2027.
这项倡议旨在从2026年和2027年开始提供更低的药品价格。
The first round of negotiations focused on ten specific drugs. When the new prices take effect in 2026, Medicare recipients should save approximately $1.5 billion in out-of-pocket costs.
第一轮谈判主要集中在十种特定药品上。当新价格于2026年生效时，医疗保险受益人应该能够节省大约15亿美元的个人费用。
- Is The iPhone Losing Its Buzz Among Teens? Piper Sandler Finds Out
- 青少年中的iPhone是否正在失去吸引力？派杰投资正在调查
Image via Shutterstock
图片来自shutterstock。